Net profit of Aurobindo Pharma declined 0.58% to Rs 903.47 crore in the quarter ended March 2025 as against Rs 908.75 crore during the previous quarter ended March 2024. Sales rose 11.87% to Rs 8381.12 crore in the quarter ended March 2025 as against Rs 7491.92 crore during the previous quarter ended March 2024.
For the full year,net profit rose 9.86% to Rs 3485.88 crore in the year ended March 2025 as against Rs 3172.97 crore during the previous year ended March 2024. Sales rose 9.31% to Rs 31378.13 crore in the year ended March 2025 as against Rs 28704.50 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 8381.12 | 7491.92 | 12 | 31378.13 | 28704.50 | 9 |
| OPM % | 21.00 | 22.16 | - | 20.88 | 20.30 | - |
| PBDT | 1779.52 | 1706.34 | 4 | 6715.71 | 6093.51 | 10 |
| PBT | 1335.09 | 1352.01 | -1 | 5066.29 | 4571.85 | 11 |
| NP | 903.47 | 908.75 | -1 | 3485.88 | 3172.97 | 10 |